Pay TV Market Size Is Anticipated To Reach USD 265.44 Billion by 2028

 Pay TV Market Growth & Trends

The global pay TV market size is anticipated to reach USD 265.44 billion by 2028, exhibiting a CAGR of 1.7% over the forecast period, according to a new report by Grand View Research, Inc. Rising competition from OTT media providers is promoting pay TV operators to disrupt existing business models and strategize more efficient profit generation methodologies. Additionally, emerging players, such as MOBITV, offer customized, cost-effective, and flexible options to their customers according to their demands, thus ensuring customer satisfaction. This is expected to promote new and existing players to diversify their existing service offerings and ensure healthy competition in the market. 

The IPTV segment is expected to witness significant market growth over the forecast period due to the advent of 5G technology. Increased bandwidth and enhanced ability to build virtual end-to-end networks for specific applications is a major driving factor for the industry growth. Additionally, the rapid proliferation of the 5G delivery model in emerging economies is expected to provide consumers with a high-definition 4K viewing experience. Moreover, the adoption of 5G integrated with IPTV services is expected to enable the hospitality industry to improve its service offerings. The technology is expected to facilitate more efficient data collection, analysis, and optimization; to offer a more personalized TV viewing experience to its guests.

Furthermore, Multi-access Edge Computing (MEC) technology is expected to bring content and applications closer to the network edge, thus reducing latency and enable service optimization. MEC facilitates users to access content with minimum delay and increase IPTV network capacity via Software-Defined Networks (SDN), which improves the user’s quality of experience, thus offering encouraging growth prospects to the market. Additionally, MEC is also expected to offer enhanced security to the network system by safeguarding viewers’ information and television viewing trends, which is expected to offer an impetus to the market growth.

Rising demand amongst customers to access television viewing experience from anywhere in the world on various devices such as mobile phones and tabs is promoting service providers to adopt cloud computing methodologies. Cloud computing offers a flexible and unified platform to holistically manage content monetization and security, thus enabling service providers to simplify business practices. Furthermore, the adoption of cloud technology also enables service providers to leverage the ‘as-a-service’ business model, thereby helping to generate new and sustained revenue streams.

Request a free sample copy or view report summary: Pay TV Market Report

Pay TV Market Report Highlights

• The IPTV segment is expected to witness the highest CAGR of more than 8%, owing to augment of OTT media platforms and its high adoption rate amongst customers
• Satellite TV segment will continue to witness incrementing market growth. This growth can be associated with the provision of offering customers with low-priced access to live coverage of important events
• The Asia Pacific region is expected to emerge as the fastest-growing regional market due to comparatively lower internet rates and daily upgrades being made, thus ensuring easier access to consumers
• Some of the key players in the market are DIRECTV, DISH Network Corporation, Carter Communications, Foxtel, and Comcast Corporation

Access Press Release@ https://www.grandviewresearch.com/press-release/global-pay-television-tv-market

Pay TV Market Segmentation

Grand View Research has segmented the global pay TV market based on technology and region:

Pay TV Technology Outlook (Subscribers, Million; Revenue, USD Billion, 2018 - 2028)

• Cable TV
• Satellite TV
• Internet Protocol Television (IPTV)

Pay TV Regional Outlook (Subscribers, Million; Revenue, USD Billion, 2018 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
  • Mexico
• MEA

List of Key Players of Pay TV Market

• DIRECTV
• DISH Network Corporation
• Carter Communications
• Foxtel
• Comcast Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Automotive Infotainment Market to Exhibit Impressive Growth During 2021 – 2028: Grand View Research Inc.

 Automotive Infotainment Market Growth & Trends

The global automotive infotainment market size is expected to reach USD 12.57 billion by 2028, registering a CAGR of 8.7% from 2021 to 2028, according to a new report by Grand View Research, Inc. The increasing demand for autonomous vehicle technology, automotive cockpit electronics, and advanced safety features such as advanced driver assistance systems is anticipated to drive the growth. The growing demand for enhanced in-vehicle experience and shifting consumer buying behavior and the worldwide expansion of the luxury and premium car segments are also likely to fuel the growth of the market.

The growing number of millennials opting for small and medium-sized cars is expected to boost the growth of the market growth. Furthermore, consumers are inclined to buy these cars, compared to premium cars, owing to their cost-effectiveness. In addition to this, the introduction of medium-sized SUVs has further encouraged the market growth as consumers can buy a bigger-sized vehicle at a lower cost.

Automotive infotainment technology is expected to gain significant demand as major automotive components and solution providers are engaging in developing complete automotive infotainment solutions. For instance, in May 2021, BMW AG announced iDrive 8, the latest infotainment system for its vehicles. The new iDrive 8 provides enhanced voice-recognition software and a massive touchscreen with multiple new features. It will be initially debuted on the new electric i4 sedan and iX SUV.

The introduction of Artificial Intelligence (AI)-based infotainment systems is also expected to contribute to the market growth. However, the market is characterized by a negligible regulatory framework regarding product manufacturing, resulting in counterfeit and low-quality products. Such negative trends are expected to hinder the market growth.

Emerging economies such as China and India are expected to contribute significantly to the growth of the market for automotive infotainment. The development is characterized by the increase in the adoption of mid-sized cars, which enables automotive companies to offer infotainment products for this car segment.

Request a free sample copy or view report summary: Automotive Infotainment Market Report

Automotive Infotainment Market Report Highlights

• The head-up displaysegment is expected to expand at the highest CAGR of around 10% over the forecast period owing to the integration of augmented reality for enhanced safety and driving experience
• The OF fitted segment dominated the market in 2020 and is anticipated to generate over USD 9.6 billion by 2028 owing to the benefits such as easier servicing and maintenance
• The passenger car segment accounted for the largest revenue share of around 80% of the overall market in 2020. The increasing demand for connected carfeatures in passenger vehicles and the onset of autonomous vehicles are expected to drive the growth of this segment
• Asia Pacific accounted for the largest market share in 2020. The regional market growth can be attributed to the increased production and sales of passenger vehicles in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-automotive-infotainment-systems-market

Automotive Infotainment Market Segmentation

Grand View Research has segmented the global automotive infotainment market based on product type, fit type, vehicle type, and region:

Automotive Infotainment Product Type Outlook (Volume, Units; Revenue, USD Billion, 2016 - 2028)

• Audio Unit
• Display Unit
• Heads-Up Display
• Navigation Unit
• Communication Unit

Automotive Infotainment Fit Type Outlook (Volume, Units; Revenue, USD Billion, 2016 - 2028)

• OE Fitted
• Aftermarket

Automotive Infotainment Vehicle Type Outlook (Volume, Units; Revenue, USD Billion, 2016 - 2028)

• Passenger Cars
• Commercial Vehicles

Automotive Infotainment Regional Outlook (Volume, Units; Revenue, USD Billion, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa

List of Key Players in the Automotive Infotainment Market

• Alpine Electronics
• Clarion Co., Ltd.
• Continental AG
• Delphi Automotive PLC
• Denso Corporation
• Harman International
• JVC KENWOOD Corporation
• Panasonic Corporation
• Pioneer Corporation
• Visteon Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

B2C E-commerce - The Online Shopping Boom, Explained

 

Know More- https://www.grandviewresearch.com/industry-analysis/b2c-e-commerce-market

The growth can be attributed to the rising disposable income, global per capita income, and expanding internet penetration. The increasing technological adoption accompanied by the easy availability of smartphones has enabled the e-commerce sector to be more reachable and efficient. The increasing use of social networks is further driving the demand for online purchasing of various products and services. The market is expected to witness high growth over the forecast period mainly due to growing digital dependency and the convenience of shopping on online platforms. It has evolved amid a busy lifestyle and an overabundance of options available to shop from the comfort of home.

Revolutionize Agriculture With Vertical Farming

 

Know More- https://www.grandviewresearch.com/industry-analysis/vertical-farming-market

This is attributed to the growing adoption of environment-friendly production of fruits and vegetables. The unprecedented growth of the global population has increased the demand for urban agriculture. Vertical farming is the practice of producing food in a vertically stacked-layer such as a used warehouse, skyscraper, or shipping container. Organic foods are perceived as healthier, nutritious, safer, and more environmentally friendly. A critical factor that influences the demand for organic food is the food purchasing behavior of consumers, which is essential for producers, policymakers, and suppliers to implement successful marketing strategies.

Antibody Drug Conjugate Market Significant Profits Estimated to be Generated by 2028: Grand View Research Inc.

 

Antibody Drug Conjugate Market Growth & Trends

The global antibody drug conjugate market size is expected to reach USD 23.9 billion by 2028, according to a new report by Grand View Research Inc. The market is expected to grow at a CAGR of 23.7% from 2021 to 2028. Increasing investment in R&D and advancements in linker technology are expected to boost the growth of the antibody drug conjugates (ADCs) market.

Antibody-drug conjugates are a novel category of drugs composed of an antibody linked to a cytotoxic drug with a linker. Conventional chemotherapy is intended to kill fast-growing tumor cells. However, it can also damage healthy proliferating cells, which may produce undesirable effects. In contrast, ADCs are designed to increase the efficacy of treatment and decrease the systemic toxicity of chemotherapy drugs. Major players are entering into partnerships for the development & commercialization of these products. For instance, in July 2020, AstraZeneca collaborated with Daiichi Sankyo to develop and commercialize its new ADC candidate, DS-1062, which is in phase 1 trials for triple-negative breast cancer and Non-Small Cell Lung Cancer (NSCLC).

One of the major factors responsible for the growth of the ADCs market is the rising incidence and prevalence of cancer coupled with the growing geriatric population. According to the Cancer Research U.K., during 2015-2017, on average, nearly 36% of new cases were reported among people aged 75 years & above, each year. It is further estimated that by 2035, almost 46% of all cancer cases will be among people in the age group of 75 years & above. Moreover, the rise in the prevalence of cancer in emerging countries further boosts growth. According to Globocan, in 2020, approximately 49.2% of global cancer cases were registered in Asia. Thus, this region remains a major untapped market for ADCs.

ADCs manufacturing is a complicated and expensive process, which requires high capital investment and trained operators, stringent GMP, and high operational difficulties. Challenges in downstream processing of ADCs might restrict the market growth. These include handling MAb-linker-drug binding chemistries, balancing & combining optimal MAb specificity, preventing premature toxin release, and controlling the release of intracellular toxin. Furthermore, the lack of availability of reimbursement policies in developing economies is expected to restrict market growth.

Mergers and acquisitions are one of the key strategies employed by key players to increase their market share. For instance, in December 2020, Boehringer Ingelheim acquired NBE-Therapeutics for USD 1.44 billion. NBE-Therapeutics’ expertise in proprietary platforms for ADC development is expected to help Boehringer Ingelheim in the development of ADC drugs.

Request a free sample copy or view report summary: Antibody Drug Conjugate Market Report

Antibody Drug Conjugate Market Report Highlights

• Breast cancer was the largest revenue-generating segment in 2020 due to a high number of approved ADC products, approval of Kadcyla for early-stage breast cancer, and a high target patient population
• The cleavable linker segment dominated the market in 2020 due to its wide adoption in ADC’s product development
• Most of the pipeline and commercially available ADCs are based on cleavable linker technology
• Asia Pacific is expected to witness the fastest CAGR over the forecast period
• This growth can be credited to the increasing investments in R&D by local players and the rising geriatric population in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-antibody-drug-conjugates-market

Antibody Drug Conjugate Market Segmentation

Grand View Research has segmented the global antibody drug conjugate market on the basis of application, technology, and region:

ADCs Application Outlook (Revenue, USD Million, 2017 - 2028)

• Blood Cancer
  • Leukemia
  • Multiple Myeloma
  • Lymphoma
• Breast Cancer
• Urothelial Cancer & Bladder Cancer
• Others

ADCs TechnologyOutlook (Revenue, USD Million, 2017 - 2028)

• Cleavable Linker
• Non-cleavable Linker
• Linkerless

ADCs Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • Italy
  • Spain
  • France
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Antibody Drug Conjugate Market

• Takeda Pharmaceutical Company Ltd.
• Hoffmann-La Roche Ltd.
• Pfizer, Inc.
• AstraZeneca
• Gilead Sciences, Inc.
• Astellas Pharma
• Seagen, Inc.
• Daiichi Sankyo Company Ltd.
• GlaxoSmithKline Plc
• ADC Therapeutics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Endotracheal Tube Market Size Is Expected To Reach USD 3.1 Billion by 2028

 Endotracheal Tube Market Growth & Trends

The global endotracheal tube market size is expected to reach USD 3.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.2% from 2021 to 2028. Endotracheal tubes are used to supply oxygen or other gases to the lungs. The rising prevalence of chronic diseases such as respiratory, cardiovascular diseases, and an increasing number of surgical procedures, are expected to propel market growth. In addition, technological development pertaining to endotracheal tubes is further expected to contribute to significant market activities during the forecast period. Recently, Medtronic has launched a Shiley laser oral endotracheal tubes that are most widely used for ventilation during CO₂ and Potassium Titanyl Phosphate (KTP) laser surgeries of the laryngeal or tracheal area.

Certain key factors contributing towards market revenue are the growing need for ventilator-associated with pneumonia and increasing geriatric population that are prone to chronic diseases. As per the World Health Organization (WHO) Report 2019, 4,000,000 people die prematurely due to non-treatment of chronic respiratory diseases. A prominent reason for increasing prevalence of respiratory diseases is air pollution. According to the WHO Report 2019, around 2 billion people globally are exposed to indoor toxic air, 1 billion people are exposed to outdoor pollutant air, and around 1 billion people are exposed to tobacco smoke. The above factors are likely to boost the prevalence of respiratory disorders, which in turn shall boost the demand for endotracheal tubes. With opportunities existing, manufacturers are investing in increasing awareness about the technologically advanced endotracheal tube. For instance, and developments in the field of nanobiotechnology and drug design are spaces that may exhibit higher activities for market growth.

The market witnessed a surge after the outbreak of COVID-19 as breathing difficulty is one of the primary symptoms of the infection, which can lead to collapsed lungs. According to American Association for Bronchology and Interventional Pulmonology, performing tracheostomy was recommended in Covid-19 patients with prolonged mechanical ventilation as it is can reduce the risk of infection, further contributing to market growth. However, a sudden upsurge led to certain mismanagement and chaos initially. By the end of 2020, the industry players had geared themselves up to meet all necessary demands, as well as offer smooth product distribution.

Request a free sample copy or view report summary: Endotracheal Tube Market Report

Endotracheal Tube Market Report Highlights

• By product type, the regular endotracheal tube segment held the largest revenue share of 32.0% in 2020 owing to the increasing prevalence of respiratory diseases
• The orotracheal segment held the largest revenue share and accounted for 64.9% in 2020 owing to its high applicability, increased usage, and ease of use
• Based on the end-use segment, the clinics segment accounted for the largest revenue share in 2020 owing to the shorter waiting time at clinics, convenient access to care, and affordability
• North America accounted for the highest revenue share of 37.9% in 2020 owing to the advanced healthcare system and the growing prevalence of chronic diseases in the region
• Asia Pacific is expected to witness the fastest CAGR of 7.7% over the forecast period. Development in healthcare infrastructure is resulting in an increased number of surgeries being performed, eventually fueling market growth in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-endotracheal-tubes-market

Endotracheal Tube Market Segmentation

Grand View Research has segmented the global endotracheal tubes market based on product type, route type, application, end-use, and region:

Endotracheal Tube Product Type Outlook (Revenue, USD Million, 2018 - 2028)

• Regular
• Reinforced
• Preformed
• Double lumen

Endotracheal Tube Route Type Outlook (Revenue, USD Million, 2018 - 2028)

• Orotracheal
• Nasotracheal

Endotracheal Tube Application Outlook (Revenue, USD Million, 2018 - 2028)

• Emergency Treatment
• Therapy
• Others

Endotracheal Tube End-use Outlook (Revenue, USD Million, 2018 - 2028)

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

Endotracheal Tube Regional Outlook (Revenue, USD Million, 2018 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Belgium
  • Switzerland
  • Russia
  • Sweden
• Asia Pacific
  • India
  • Japan
  • China
  • Australia
  • South Korea
  • Malaysia
  • New Zealand
  • Singapore
  • Philippines
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Endotracheal Tube Market

• Teleflex Corporation
• Medtronic
• Medline Industries
• Venner Medical
• Sonoma Pharmaceutical
• Hospiteknik Healthcare
• Armstrong Medical
• Airway Innovations
• Smiths Group
• ConvaTec, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Market for Ophthalmic Perimeters to Reflect Steadfast Expansion During 2021-2028: Grand View Research Inc.

 Ophthalmic Perimeters Market Growth & Trends

The global ophthalmic perimeters market size is anticipated to reach USD 371.7 million by 2028, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 4.3% over the forecast period. The growing frequency of new product launches and an increasing number of strategic alliances between players & end-users are some of the major factors expected to boost growth.

North America is anticipated to dominate the ophthalmic perimeters market during the forecast period owing to rising lifestyle and age-associated ophthalmic conditions such as glaucoma and cataract. An increase in demand for advanced early diagnostic techniques, a high adoption rate for advanced technologies, and favorable reimbursement scenarios are some of the major factors driving the market in the region.

A significant number of ophthalmic perimeter manufacturers are in North America. These players are emphasizing on developing user-friendly ophthalmic perimeter devices by developing image processing software. Moreover, key players are conducting workshops and training programs. Such initiatives are expected to boost the overall growth. The market is witnessing a rise in technologically advanced ophthalmic perimeter devices in the market due to high competition. The development of patented, tablet-based visual field testing and analysis system is anticipated to enable easy, faster, & accurate diagnosis.

Request a free sample copy or view report summary: Ophthalmic Perimeters Market Report

Ophthalmic Perimeters Market Report Highlights

• Static perimeters segment held maximum share in 2018 owing to its extensive use in capturing large data points for visual field testing. Moreover, these devices conduct visual field testing from multiple angles, which in turn helps with an accurate diagnosis.
• Combination perimeters segment is expected to grow at the fastest pace during the forecast period. These devices enable the standardization of procedures and decrease the overall turnaround time.
• Hospital held the largest share among the end-use segment. The high demand for advanced ophthalmic perimeters in hospitals is driving the segment growth.
• Ophthalmic clinic is expected to experience the fastest growth during the forecast period. The segment growth is fueled by an increasing number of standalone ophthalmic clinics in developing regions.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-ophthalmic-perimeters-market

Ophthalmic Perimeters Market Segmentation

Grand View Research has segmented the global ophthalmic perimeters market on the basis of product, application, end-use, and region:

Ophthalmic Perimeters Product Outlook (Revenue, USD Million, 2016 - 2028)

• Static
• Kinetic
• Combination

Ophthalmic Perimeters End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospital
• Ophthalmic Clinic
• Others

Ophthalmic Perimeters Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of the Ophthalmic Perimeters Market

• Haag-Streit AG
• Carl Zeiss AG
• Topcon Corporation
• Nidek Co., Ltd.
• Heidelberg Engineering GmbH
• Optopol Technology Sp. z o.o.
• Takagi Seiko Co., Ltd.
• Kowa Company, Ltd.
• Metrovision
• Konan Medical USA, Inc.
• Centervue S.P.A.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Point-of-Care Glucose Testing Market Trends Analysis And Forecast Till 2028: Grand View Research Inc.

 Point-of-Care Glucose Testing Market Growth & Trends

The global point-of-care glucose testing market size is expected to reach USD 4.1 billion by 2028 growing at a CAGR of 3.9%, according to a new report by Grand View Research, Inc. An increase in the demand for point-of-care testing (POCT) has been witnessed in recent years. As compared to the conventional laboratory testing performed central lab settings, glucose POCT aids in performing effective diagnosis at the patient’s bedside. Easy and convenient operation of POCT has largely favored the growing usage of glucose meters across medical settings. 

The demand for performing bedside monitoring of blood sugar levels efficiently in a capillary blood sample and the need to ensure better management of carbohydrate metabolism has propelled the point-of-care glucose testing market players to launch innovative glucose meters in the market. Various companies are investing in the development of needle-less blood glucose monitoring devices to offer painless management of diabetes in patients.

For instance, GlucoTrack - a product manufactured by Integrity Applications (Israel) performs quantification using electromagnetic, ultrasonic, and thermal waves in combination. In addition, Eversense is another painless glucose monitoring subcutaneous implant offered by Senseonics. This implant is able to quantify glucose levels in interstitial fluid when placed beneath the skin. This is followed by data transmission to show the results in real time.

The latest no-code monitoring systems help in minimizing the errors that occur due to incorrect entry of strip codes. Whereas, others are incorporating noble metals such as silver, gold, and platinum which effectively reduces the electrical noise further improving accuracy.

Request a free sample copy or view report summary: Point-of-Care Glucose Testing Market Report

Point-of-Care Glucose Testing Market Report Highlights

• Accu-Chek Inform II accounted for the largest revenue share in 2018 and is anticipated to maintain this trend throughout the forecast period
• Bayer CONTOUR blood glucose monitoring system is set to grow with a CAGR of 5.5% from 2019-2025
• In terms of volume, the i-STAT ranked above all owing to its multipurpose utility in the diagnostics industry
• North America is the leading regional market due to the higher penetration of novel diagnostic techniques
• Asia Pacific has registered the fastest growth rate owing to numerous untapped growth opportunities in diagnostics and ever-increasing prevalence of diabetes
• A robust network of local manufacturers has significantly contributed to the revenue generated in this region Some of the key market participants are F. Hoffmann-La Roche Ltd., Abbott, LifeScan, Inc., and Nova Biomedical among others

Access Press Release@ https://www.grandviewresearch.com/press-release/global-point-of-care-glucose-testing-market

Point-of-Care Glucose Testing Market Segmentation

Grand View Research has segmented the global point-of-care glucose testing market on the basis of product and region:

Point-of-Care Glucose Testing Product Outlook (Revenue, USD Million, 2016 - 2028)

• Accu-Chek Inform II
• StatStrip
• Onetouch Verio Flex
• Freestyle Lite
• Accu Check Aviva Meter
• True Metrix
• Bayer CONTOUR Blood Glucose Monitoring System
• i-STAT

Point-of-Care Glucose Testing Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Point-of-Care Glucose Testing Market

• Hoffmann-La Roche Ltd.
• Abbott
• Nipro
• PlatInium Equity Advisors, LLC (Lifescan, Inc.)
• Nova Biomedical
• ACON Laboratories
• Trividia Health, Inc.
• Prodigy Diabetes Care, LLC
• Bayer AG/Ascensia Diabetes Care Holdings AG
• EKF Diagnostics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Chemiluminescence Immunoassay Market Significant Profits Estimated to be Generated by 2028: Grand View Research Inc.

 Chemiluminescence Immunoassay Market Growth & Trends

The global chemiluminescence immunoassay market size is expected to reach USD 13.75 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.9% from 2021 to 2028. The high prevalence of chronic diseases, several advantages of chemiluminescence immunoassay (CLIA) technique, and approval and launch of novel CLIA solutions are anticipated to be the major factors driving the market.

Key players in the market are implementing organic and inorganic growth strategies for the development, launch, and distribution of novel CLIA solutions. For instance, in February 2020, Snibe Diagnostic, a China-based immunoassay manufacturer, received CE marking for its new MAGLUMI 2019-nCoV (SARS-CoV-2) IgM/IgG CLIA kits. In another instance, in January 2018, DiaSorin partnered with Germany-based Qiagen and added Qiagen’s QuantiFERON-TB diagnostic test portfolio to its LIAISON family of fully automated chemiluminescence immunoassay analyzers. Such initiatives by major players are anticipated to significantly support the market growth. However, the high setup cost of automated chemiluminescence immunoassay systems is expected to be a major factor hindering the market growth.

Furthermore, the high prevalence of chronic diseases in key regions and increasing awareness regarding these diseases in emerging economies are anticipated to upsurge the demand for novel diagnostic solutions, including chemiluminescence immunoassay. According to the data published by the American Cancer Society, in 2020, an estimated 1.8 million new cases of cancer were diagnosed in the U.S. and around 606,520 people died due to the disease. In addition, as per the data published by the WHO in November 2020, HIV emerged as a major global public health issue and around 37.9 million people around the globe were living with the disease.

Request a free sample copy or view report summary: Chemiluminescence Immunoassay Market Report

Chemiluminescence Immunoassay Market Report Highlights

• Based on product, consumables dominated the market in 2020 owing to their high demand in therapeutic drug monitoring, endocrinology, and disease diagnosis
• In terms of application, the infectious disease segment held the largest share in 2020 owing to the high prevalence of such diseases and the launch of novel CLIA assays for infectious disease diagnosis
• By end use, in 2020, the hospitals segment accounted for the largest share in 2020 owing to the increasing hospitalizations, along with the rising prevalence of chronic diseases
• In North America, the U.S. held the largest share in 2020 owing to the developed healthcare infrastructure, the high adoption of technologically advanced CLIA systems, and the strong geographical presence of prominent players
• Asia Pacific is expected to expand at the fastest CAGR during the forecast period. The emergence of local players in developing markets, such as India and China, is primarily driving the regional market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-chemiluminescence-immunoassay-market

Chemiluminescence Immunoassay Market Segmentation

Grand View Research has segmented the global chemiluminescence immunoassay market on the basis of product, application, end-use, and region:

Chemiluminescence Immunoassay Product Outlook (Revenue, USD Million, 2016 - 2028)

• Instruments
  • Automated
  • Semi-automated
• Consumables
• Software & Services

Chemiluminescence Immunoassay Application Outlook (Revenue, USD Million, 2016 - 2028)

• Therapeutic Drug Monitoring
• Oncology
• Cardiology
• Endocrinology
• Infectious Disease
• Autoimmune Disease
• Others

Chemiluminescence Immunoassay End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Clinical Laboratories
• Pharmaceutical & Biotechnology Companies
• Others

Chemiluminescence Immunoassay Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
  • France
  • Italy
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Chemiluminescence Immunoassay Market

• DiaSorin S.p.A.
• Abbott Laboratories
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Immunodiagnostic Systems
• Siemens Healthineers
• Beckman Coulter Inc.
• Hoffmann-La Roche AG
• Inova Diagnostics, Inc.
• Maccura Biotechnology Co., Ltd.
• Ortho Clinical Diagnostics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Building-integrated Photovoltaics - Favorable Government Policies for Renewable Energy Installations

 

Know More- https://www.grandviewresearch.com/industry-analysis/building-integrated-photovoltaics-bipv-market

The increasing efforts by the national governments for the installation of solar energy panels are anticipated to drive the market over the next seven years. The rising awareness regarding green infrastructure, including buildings with energy efficiency, is expected to boost the demand for building-integrated photovoltaics (BIPV). BIPV provides a sustainable and effective solution for enhancing the energy efficiency of the structure, retrofitting the exterior of the structure, and providing significant savings in conventional power consumption.

Optical Character Recognition - Increasing Investments In OCR Startup Companies

 

Know More- https://www.grandviewresearch.com/industry-analysis/optical-character-recognition-market

The optical character recognition technology is used to convert content on physical documents into digital form. It helps users to convert different types of images and documents into an editable format. Furthermore, it is used in various industries, such as the logistics and transportation industry, BFSI, and others. Government, banking, retail, healthcare, manufacturing, and other sectors also have wide adoption for OCR technology. With the rising age of digitalization, enterprises invest a lot of money in technologies to increase work efficiency and productivity. 

COVID-19 Vaccine Development Tools Market to Reflect a Holistic Expansion During 2021 to 2028: Grand View Research Inc.

 COVID-19 Vaccine Development Tools Market Growth & Trends

The global COVID-19 vaccine development tools market size is expected to reach USD 30.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.6% from 2021 to 2028. Research professionals across the globe, are rapidly persuading the identification and development of viable candidates to develop COVID-19 immunization shots. This is attributed to the persisting devastation of SARS-CoV-2 across the globe. Additionally, second waves of SARS-CoV-2 infection were expected to coincide with the beginning of winter in the northern hemisphere, indicating the crucial period in the pandemic’s timeline.

Thus, the development of a viable immunization shot is imperative to mitigate the global impact of COVID-19. Acknowledging this need, entities engaged in the development of effective inoculation against COVID-19, are aiming at 4 potential key vaccine candidates, namely, mRNA, recombinant, inactivated, and replication-deficient viral vector. These 4 candidates are the key areas of focus, and the integration of mass spectrometry and chromatography for candidate characterization is common across the development process of all the above candidates.

The spike protein (S-protein) is the most preferred target site with respect to the COVID-19 vaccine target discovery. This is attributed to the fact that the S-proteins are spread throughout the surface of the COVID-19 molecule, which enables attachment to host cell receptors, in turn ensuring easy entry of the virus into the host cell. Active government initiatives aimed at enabling the fast-track development of COVID-19 boosters are expected to create a favorable environment for entities operating in the industry.

For instance, in April 2020, the Access to COVID-19 Tools (ACT) Accelerator was launched aimed at speeding up the delivery and development of COVID-19 boosters. This initiative is inclusive of a health systems connector that supports the delivery of required resources to countries. The tools are also pooled under the umbrella mechanism, namely, the COVAX Facility to ensure effective procurement as well as equitable access to, COVID-19 vaccination and development tools. The ACT Accelerator targets to deliver around 2 billion doses by the end of 2021, across the globe.

Request a free sample copy or view report summary: COVID-19 Vaccine Development Tools Market Report

COVID-19 Vaccine Development Tools Market Report Highlights

• Laboratory technologies have generated the highest revenue in 2020 and this segment is anticipated to maintain its dominance throughout the forecast period
• Significant growth in the adoption of pre-existing laboratory technologies such as PCR, 3D and 2D cell culture products, and flow cytometry is attributive to the segment’s dominance
• The PCR and qPCR segment dominated the market in terms of revenue share in 2020
• The WHO recommends the implementation of rRT-PCR in surveillance of participants for effective COVID-19 vaccine evaluation, which has supplemented a significant surge in the uptake of PCR products
• Detecting new mutations in SARS-CoV-2 enables research professionals to reconstruct unknown infection routes along with establishing a molecular basis for COVID-19 vaccine design
• This has widely promoted the usage of NGS particularly across molecular typing and genomic epidemiology applications, making it the fastest-growing segment throughout the forecast period
• Interactive web tools have emerged as dominant online technologies employed in COVID-19 vaccine development and research
• Online interactive web tools have gained sufficient traction amongst the researchers and vaccine developers as these entail interactive graphs, maps, and dashboards that assist in effective monitoring of vaccine development while avoiding any misinformation
• Vaccine research has witnessed the highest penetration of COVID-19 vaccine development tools, leading to the segment’s largest share in 2020
• Large-scale adoption of tools associated with nucleic acid isolation and purification, real-time PCR, Sanger sequencing, mass spectrometry, and NGS among others has contributed to the segment’s dominance
• The contract research organization (CROs) end-use segment is expected to grow at a fast pace through 2021 - 2028. Partnerships with CROs are proving integral as they ensure access to a vast number of resources along with expanded expertise
• North America dominated the market and accounted for the largest revenue share in 2020; U.S. ranked 1^stin this region, in terms of revenue
• More than 20% of the vaccines being developed across the globe hail from the U.S., thus, providing immense lucrative opportunities for the market players operational in the country

Access Press Release@ https://www.grandviewresearch.com/press-release/global-covid-19-vaccine-development-tools-market

COVID-19 Vaccine Development Tools Market Segmentation

Grand View Research has segmented the global COVID-19 vaccine development tools market on the basis of technology, application, end use, and region:

COVID-19 Vaccine Development Tools Technology Outlook (Revenue, USD Million, 2020 - 2028)

• Laboratory Technologies
  • Next Generation Sequencing
  • PCR & qPCR
  • Flow Cytometry
  • Spectrometry
  • Microscopy&Electron Microscopy
  • Preparative & Process Chromatography
  • Nucleic Acid Isolation & Purification
  • Transfection Electroporation
  • Cell Culture
  • Automated Liquid Handling
• Online Technologies
  • Interactive Web Technologies
  • Vaccine Management & Tracker Technologies

COVID-19 Vaccine Development Tools Application Outlook (Revenue, USD Million, 2020 - 2028)

• Vaccine Research
• Vaccine Process Development
• Vaccine Quality Assurance/Quality Control

COVID-19 Vaccine Development Tools End-use Outlook (Revenue, USD Million, 2020 - 2028)

• Pharma & Biopharma Companies
• Contract Research Organization (CROs)
• Academic & Research Institutes

COVID-19 Vaccine Development Tools Regional Outlook (Revenue, USD Million, 2020 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Italy
  • France
  • Spain
  • Russia
• Asia Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of COVID-19 Vaccine Development Tools Market

• Thermo Fisher Scientific, Inc.
• Celerion
• Cole-Parmer Instrument Company, LLC.
• Pfizer Inc.
• Sartorius AG
• STEMCELL Technologies Inc.
• AB SciexPte. Ltd.
• Illumina, Inc.
• Agilent Technologies
• Bio-Rad Laboratories, Inc.
• Danaher
• Merck KGaA
• Qiagen N.V.
• Shimadzu Corporation
• Eurofins Scientific
• Charles River Laboratories
• Takara Bio Inc.
• PerkinElmer Inc.
• Fluidigm
• OLYMPUS CORPORATION
• Avantor, Inc.
• Polyplus Transfection
• Hamilton Company
• Aurora Biomed Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Intravenous Immunoglobulin Market Outlook, Leading Manufacturers, Industry Analysis And Forecast: Grand View Research Inc.

 U.S. Intravenous Immunoglobulin Market Growth & Trends

The U.S. intravenous immunoglobulin market size is expected to reach USD 10.24 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.8% from 2021 to 2028. Robust pipeline, approval and launch of novel products, and increasing government initiatives are expected to be the major factors driving the market.

Robust pipeline and increasing approvals and launches of novel products are anticipated to support the market growth over the forecast period. For instance, in April 2019, U.S.-based ADMA Biologics, Inc. received U.S. FDA approval for its new drug Asceniv. It is an IVIG drug indicated for the treatment of primary humoral immunodeficiency disease. Similarly, in December 2019, CSL Behring announced receiving orphan drug exclusivity for Hizentra from the U.S. FDA to treat Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP). In another instance, in February 2021, Biotest AG announced that it was the first in Germany to manufacture an investigational hyper immunoglobulin from plasma protein for the COVID-19 treatment.

Furthermore, increasing initiatives by various government organizations to boost the development of novel products are expected to support market growth over the forecast period. For instance, in January 2018, the National Institutes of Health (NIH) awarded a grant of USD 3 million to the U.S.-based GigaGen Inc. to develop novel recombinant intravenous immunoglobulin for patients with primary immunodeficiency diseases.

However, the manufacturing of IVIG requires a well-developed production facility and high capital investments, thereby leading to the high cost of the final product. Hence, this factor is anticipated to restrain the market growth. In addition, IVIG products undergo stringent regulations pertaining to safety and handling, which is another factor expected to impede the market growth. For instance, in 2018, the U.S. FDA delayed the approval of GC Pharma’s intravenous immunoglobulin product and demanded additional data related to the drug’s manufacturing process.

Request a free sample copy or view report summary: U.S. Intravenous Immunoglobulin Market Report

U.S. Intravenous Immunoglobulin Market Report Highlights

• By application, immunodeficiency diseases dominated the market in 2020 owing to the rising number of cases and the growing adoption of IVIG for the treatment of these diseases
• The multifocal motor neuropathy application segment is expected to register the fastest growth rate over the forecast period due to the high effectivity of IVIG in its treatment
• Based on distribution channel, hospital pharmacy held the largest share in 2020 owing to a large number of hospital pharmacies and the easy availability of products in the hospitals
• Market leaders are involved in the development of new plasma collection centers and other collaborative strategies to expand their geographical reach and widen their product portfolio

Access Press Release@ https://www.grandviewresearch.com/press-release/us-intravenous-immunoglobulin-ivig-market-analysis

U.S. Intravenous Immunoglobulin Market Segmentation

Grand View Research has segmented the U.S. intravenous immunoglobulin market on the basis of application and distribution channel:

U.S. IVIG Application Outlook (Revenue, USD Million, 2016 - 2028)

• Hypogammaglobulinemia
• CIDP
• Immunodeficiency Diseases
• Congenital AIDS
• Chronic Lymphocytic Leukemia
• Myasthenia Gravis
• Multifocal Motor Neuropathy
• ITP
• Kawasaki Disease
• Guillain-barre Syndrome
• Others

U.S. IVIG Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

• Hospital Pharmacy
• Specialty Pharmacy
• Others

List of Key Players of U.S. Intravenous Immunoglobulin (IVIG) Market

• Biotest AG
• Octapharma AG
• LFB Biotechnologies S.A.S
• China Biologics Products Holdings, Inc.
• Grifols, S.A.
• Kedrion Biopharma, Inc.
• CSL Behring
• McKesson Corporation
• Takeda Pharmaceutical Company Limited
• Bio Products Laboratory Ltd.
• Pfizer, Inc.
• ADMA Biologics, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.